NEW YORK (360Dx) — Dynex Technologies announced today that it has signed a supply agreement under which its line of automated ELISA instruments will be offered for sale by Zeus Scientific to the global clinical market.
Dynex's product portfolio includes the Agility, DS2, and DSX microplate processing systems.
Specific terms of the deal were not disclosed.
"Zeus and Dynex have long worked together in an unofficial capacity," Zeus Chief Commercial Officer Chris Howard said in a statement. "Now that we are directly selling and supporting the Zeus ELISA products to the United States marketplace in conjunction with the Dynex automation systems, Zeus is positioned to offer the most flexible and efficient microplate testing options in the autoimmune and infectious disease markets."